Close

We are using cookies to give you the best experience on our site. Cookies are files stored in your browser and are used by most websites to help personalise your web experience.

By continuing to use our website without changing the settings, you are agreeing to our use of cookies.

Find out more

Cat's claw trials for rheumatoid arthritis

In this trial, 40 participants with rheumatoid arthritis took part in the following phases:

  • Phase A – participants were randomised to receive either cat’s claw tablets (60 mg of Uncariae tomentosae) or placebo tablets once a day for 24 weeks
  • Phase B – both treatment groups took cat’s claw for an additional 28 weeks.

All participants were asked to continue their usual treatment of sulfasalazine or hydroxychloroquine during both phases of the trial.

  • 53% of participants given cat’s claw in phase A reported a significant reduction in the number of painful joints compared to only 24% of participants who started on placebo tablets.
  • Participants in both groups didn’t differ with respect to morning stiffness and number of tender or swollen joints during this period.
  • Significant beneficial effects on all clinical aspects were observed in participants who were given cat’s claw for both phases when compared to the placebo group.
  • Minor side-effects (like stomach upsets) were reported in participants who received cat’s claw.

Helpline

0800 5200 520

Our new helpline: Call us for free information, help and advice on your type of arthritis. Open Mon–Fri 9am–8pm.

All calls are recorded for training and quality purposes

Virtual Assistant

Our new Arthritis Virtual Assistant uses artificial intelligence to answer your arthritis related questions 24/7.

Ask a question
Close
For more information, go to www.arthritisresearchuk.org.
Arthritis Research UK fund research into the cause, treatment and cure of arthritis. You can support Arthritis Research UK by volunteering, donating or visiting our shops.